Research programme: methyl-beta-cyclodextrin - SolAeroMed

Drug Profile

Research programme: methyl-beta-cyclodextrin - SolAeroMed

Alternative Names: Methyl-β-cyclodextrin - SolAeroMed; MβCD - SolAeroMed; S-1229

Latest Information Update: 16 Jan 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SolAeroMed
  • Class Cyclodextrins
  • Mechanism of Action Surface active agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Acute lung injury; Adult respiratory distress syndrome

Most Recent Events

  • 25 Sep 2013 Preclinical trials in Acute lung injury in Canada (Inhalation)
  • 25 Sep 2013 Preclinical trials in Adult respiratory distress syndrome in Canada (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top